Om

PharmAla Biotech Holdings Inc. is a Canadian biotechnology company focused on the research, development, manufacturing, and sale of MDMA and broader MDXX-class molecules. Its current business centers on supplying clinical-grade active pharmaceutical ingredients and related formulations to scientific researchers, as well as supporting commercial use in select jurisdictions. The company also develops novel MDXX compounds and delivery mechanisms, with work spanning process development, GMP manufacturing, and regulatory-focused supply chain operations. PharmAla Biotech Holdings Inc. serves the clinical research community through products such as LaNeo-branded materials and other specialized molecules used in pharmaceutical and laboratory settings. Headquartered in Toronto, Canada, PharmAla Biotech Holdings Inc. occupies a niche role in the biotechnology market by providing research-grade materials and specialized manufacturing capabilities for a highly regulated segment of life sciences.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PHARMALA BIOTECH HOLDINGS MED ENDAVU: Køb Pharmala Biotech Holdings ($ZO8) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Pharmala Biotech Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.